Samin Mohsenian/LinkedIn
Jul 17, 2026, 09:42
Samin Mohsenian: Proud to Receive a Top Poster Award at ISTH 2026
Samin Mohsenian, Researcher at Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, shared on LinkedIn:
”It was a pleasure to present our latest findings on congenital Factor X deficiency at ISTH 2026.
In this work, we identified clinically relevant FX activity cut-offs that may support clinical decision-making and improve bleeding risk stratification.
We also explored the genotype–phenotype relationship, highlighting how genetic variants contribute to the clinical heterogeneity observed in patients.
I was also delighted that my poster on congenital Factor VII deficiency received a Top Poster Award.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 07:05Behnood Bikdeli: Vasculearn Network Highlights Expert Perspectives on PE Risk Stratification and Advanced Therapies
-
Oct 18, 2026, 06:27Gregory Makris: NEJM Study Supports Earlier Catheter-Directed Intervention in Intermediate-High–Risk PE
-
Oct 18, 2026, 06:26Danny Hsu: BLOOD 2026 Return to Aotearoa
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?